Evidence map›Paper›PMID 31216669›Full record

ReviewCells2019

Regeneration of Dermis: Scarring and Cells Involved.

Alexandra L Rippa, Ekaterina P Kalabusheva, Ekaterina A Vorotelyak

4 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 142 papers.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05239117 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Open, Non-comparative, Multicentre Clinical Investigation to Evaluate the Performance and Safety of the Medical Device Plenhyage® (Polymerised Polynucleotides Dermal Filler) in the Treatment of Dermal Tissue Defects

TypeinterventionalSponsorI.R.A. Istituto Ricerche Applicate S.p.A.Ran2022 to 2022Enrolled48ConditionsCicatrix, Lipodystrophy, PlaqueArmsPlenhyage
NCT05239130 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Open, Non-comparative, Multicentre Clinical Investigation to Evaluate the Performance and Safety of the Medical Device Auralya® (Hyaluronic Acid-dermal Filler) in the Treatment of Facial Dermal Tissue Defects

TypeinterventionalSponsorI.R.A. Istituto Ricerche Applicate S.p.A.Ran2022 to 2022Enrolled48ConditionsCicatrix, Lipodystrophy, PlaqueArmsAuralya
NCT05239156 nacompletednot on this mapstarted 2022, after this paper: background citation

Open, Non-comparative, Multicentre Clinical Investigation to Evaluate the Performance and Safety of the Medical Device Janesse® (Hyaluronic Acid-dermal Filler) in the Treatment of Facial Dermal Tissue Defects

TypeinterventionalSponsorI.R.A. Istituto Ricerche Applicate S.p.A.Ran2022 to 2022Enrolled48ConditionsCicatrix, Lipodystrophy, PlaqueArmsJanesse
NCT05239351 nacompletednot on this mapstarted 2022, after this paper: background citation

Open, Non-comparative, Multicentre Clinical Investigation to Evaluate the Performance and Safety of the Medical Device Jalucomplex® (Hyaluronic Acid-dermal Filler) in the Treatment of Facial and Neck Dermal Tissue Defects

TypeinterventionalSponsorI.R.A. Istituto Ricerche Applicate S.p.A.Ran2022 to 2022Enrolled48ConditionsCicatrix, Lipodystrophy, PlaqueArmsJalucomplex
3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 277 citations in OpenAlex.

  1. Trial
  2. Combined Effect of Silybin and Sodium Acetylated Hyaluronate on UV-Induced Photoaging.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alexandra L RippaLaboratory of Cell Biology, N.K. Koltsov Institute of Developmental Biology, 26 Vavilov str., Moscow 119334, Russia. rippa86@yandex.ru.ORCID 0000-0001-7300-8466
Ekaterina P KalabushevaLaboratory of Cell Biology, N.K. Koltsov Institute of Developmental Biology, 26 Vavilov str., Moscow 119334, Russia. kalabusheva.e@gmail.com.
Ekaterina A VorotelyakLaboratory of Cell Biology, N.K. Koltsov Institute of Developmental Biology, 26 Vavilov str., Moscow 119334, Russia. vorotelyak@yandex.ru.ORCID 0000-0001-5405-0212
Koltzov Institute of Developmental Biology · RULomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are many studies on certain skin cell specifications and their contribution to wound healing. In this review, we provide an overview of dermal cell heterogeneity and their participation in skin repair, scar formation, and in the composition of skin substitutes. The papillary, reticular, and hair follicle associated fibroblasts differ not only topographically, but also functionally. Human skin has a number of particular characteristics that are different from murine skin. This should be taken into account in experimental procedures. Dermal cells react differently to skin wounding, remodel the extracellular matrix in their own manner, and convert to myofibroblasts to different extents. Recent studies indicate a special role of papillary fibroblasts in the favorable outcome of wound healing and epithelial-mesenchyme interactions. Neofolliculogenesis can substantially reduce scarring. The role of hair follicle mesenchyme cells in skin repair and possible therapeutic applications is discussed. Participation of dermal cell types in wound healing is described, with the addition of possible mechanisms underlying different outcomes in embryonic and adult tissues in the context of cell population characteristics and extracellular matrix composition and properties. Dermal white adipose tissue involvement in wound healing is also overviewed. Characteristics of myofibroblasts and their activity in scar formation is extensively discussed. Cellular mechanisms of scarring and possible ways for its prevention are highlighted. Data on keloid cells are provided with emphasis on their specific characteristics. We also discuss the contribution of tissue tension to the scar formation as well as the criteria and effectiveness of skin substitutes in skin reconstruction. Special attention is given to the properties of skin substitutes in terms of cell composition and the ability to prevent scarring.

Indexed as

AnimalsCicatrixDermisExtracellular MatrixFibroblastsHair FollicleHumansKeloidMyofibroblastsRegenerationSkinSkin, ArtificialSkin Physiological PhenomenaWound Healingfibroblastskeloidmyofibroblastsregenerationscarringskinskin substituteswound healing

Identifiers

PMID31216669
PMCPMC6627856
OpenAlexW2949279706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.